160 related articles for article (PubMed ID: 26927284)
21. Reconsidering the benefit of intermittent versus continuous treatment in the maintenance treatment setting of metastatic colorectal cancer.
Sunakawa Y; Bekaii-Saab T; Stintzing S
Cancer Treat Rev; 2016 Apr; 45():97-104. PubMed ID: 27002945
[TBL] [Abstract][Full Text] [Related]
22. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.
Falvella FS; Cremolini C; Miceli R; Nichetti F; Cheli S; Antoniotti C; Infante G; Martinetti A; Marmorino F; Sottotetti E; Berenato R; Caporale M; Colombo A; de Braud F; Di Bartolomeo M; Clementi E; Loupakis F; Pietrantonio F
Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121
[TBL] [Abstract][Full Text] [Related]
23. Cancer stem cell molecular reprogramming of the Warburg effect in glioblastomas: a new target gleaned from an old concept.
Yuen CA; Asuthkar S; Guda MR; Tsung AJ; Velpula KK
CNS Oncol; 2016; 5(2):101-8. PubMed ID: 26997129
[TBL] [Abstract][Full Text] [Related]
24. TWIST1 Polymorphisms Predict Survival in Patients with Metastatic Colorectal Cancer Receiving First-Line Bevacizumab plus Oxaliplatin-Based Chemotherapy.
Matsusaka S; Zhang W; Cao S; Hanna DL; Sunakawa Y; Sebio A; Ueno M; Yang D; Ning Y; Parekh A; Okazaki S; Berger MD; Ichikawa W; Mizunuma N; Lenz HJ
Mol Cancer Ther; 2016 Jun; 15(6):1405-11. PubMed ID: 26983880
[TBL] [Abstract][Full Text] [Related]
25. A sensitive and high throughput TaqMan-based reverse transcription quantitative polymerase chain reaction assay efficiently discriminates ALK rearrangement from overexpression for lung cancer FFPE specimens.
Lung J; Lin YC; Hung MS; Jiang YY; Lee KD; Lin PY; Tsai YH
Lung Cancer; 2016 Apr; 94():114-20. PubMed ID: 26973216
[TBL] [Abstract][Full Text] [Related]
26. Feasibility of cytological specimens for ALK fusion detection in patients with advanced NSCLC using the method of RT-PCR.
Wang Y; Liu Y; Zhao C; Li X; Wu C; Hou L; Zhang S; Jiang T; Chen X; Su C; Gao G; Li W; Wu F; Li A; Ren S; Zhou C; Zhang J
Lung Cancer; 2016 Apr; 94():28-34. PubMed ID: 26973203
[TBL] [Abstract][Full Text] [Related]
27. Sinusoidal dilation increases the risk of complications in hepatectomy for CRCLM - Protective effect of bevacizumab and diabetes mellitus, serum gamma-glutamyltranspeptidase as predictive factor.
Martins J; Alexandrino H; Oliveira R; Cipriano MA; Falcão D; Ferreira L; Martins R; Serôdio M; Martins M; Tralhão JG; Prado e Castro L; Castro E Sousa F
Eur J Surg Oncol; 2016 May; 42(5):713-21. PubMed ID: 26972374
[TBL] [Abstract][Full Text] [Related]
28. Is epidermal growth factor receptor tyrosine kinase inhibitor in combination with cytotoxic chemotherapy a better treatment option for patients with EGFR-mutated non-small-cell lung cancer?
Takahashi K; Saito H
Transl Lung Cancer Res; 2016 Feb; 5(1):98-101. PubMed ID: 26958501
[TBL] [Abstract][Full Text] [Related]
29. Vascular complications in glioma patients.
Le Rhun E; Perry JR
Handb Clin Neurol; 2016; 134():251-66. PubMed ID: 26948359
[TBL] [Abstract][Full Text] [Related]
30. Posterior reversible encephalopathy syndrome after bevacizumab treatment presenting to the ED as chest pain and headache.
Miller AH; Monteiro de Oliveira Novaes JA; Brock PA; Sandoval M
Am J Emerg Med; 2016 Sep; 34(9):1916.e1-2. PubMed ID: 26947375
[No Abstract] [Full Text] [Related]
31. Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation.
Zhuang H; Yuan X; Chang JY; Song Y; Wang J; Yuan Z; Wang X; Wang P
Oncotarget; 2016 Jul; 7(30):48842-48849. PubMed ID: 26934327
[TBL] [Abstract][Full Text] [Related]
32. Acquired-resistance of bevacizumab treatment for radiation brain necrosis: a case report.
Zhuang H; Yuan X; Sun D; Bian J; Chang JY; Yuan Z; Wang P
Oncotarget; 2016 Mar; 7(11):13265-13268. PubMed ID: 26933810
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of trebananib (AMG 386) in treating epithelial ovarian cancer.
Al Wadi K; Ghatage P
Expert Opin Pharmacother; 2016; 17(6):853-60. PubMed ID: 26933765
[TBL] [Abstract][Full Text] [Related]
34. Modulatory Role of Shorea robusta Bark on Glucose-metabolizing Enzymes in Diethylnitrosamine Induced Hepatocellular Carcinoma in Rats.
Kalaiselvan A; Anand T; Gokulakrishnan K; Kamaraj MC; Velavan S
Pharmacogn Mag; 2015 Oct; 11(Suppl 3):S496-500. PubMed ID: 26929587
[TBL] [Abstract][Full Text] [Related]
35. Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome.
Yılmaz S; Özçakar ZB; Taktak A; Kiremitçi S; Ensari A; Dinçaslan H; Yalçınkaya F
Pediatr Nephrol; 2016 Jun; 31(6):1029-32. PubMed ID: 26928310
[TBL] [Abstract][Full Text] [Related]
36. Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2.
Xu D; Jin J; Yu H; Zhao Z; Ma D; Zhang C; Jiang H
J Exp Clin Cancer Res; 2017 Mar; 36(1):44. PubMed ID: 28320429
[TBL] [Abstract][Full Text] [Related]
37. Prognostic role of glycolysis for cancer outcome: evidence from 86 studies.
Yu M; Chen S; Hong W; Gu Y; Huang B; Lin Y; Zhou Y; Jin H; Deng Y; Tu L; Hou B; Jian Z
J Cancer Res Clin Oncol; 2019 Apr; 145(4):967-999. PubMed ID: 30825027
[TBL] [Abstract][Full Text] [Related]
38. The association between markers of tumour cell metabolism, the tumour microenvironment and outcomes in patients with colorectal cancer.
Roseweir AK; Clark J; McSorley ST; vanWyk HC; Quinn JA; Horgan PG; McMillan DC; Park JH; Edwards J
Int J Cancer; 2019 May; 144(9):2320-2329. PubMed ID: 30521130
[TBL] [Abstract][Full Text] [Related]
39. Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity.
Xu K; Yin N; Peng M; Stamatiades EG; Shyu A; Li P; Zhang X; Do MH; Wang Z; Capistrano KJ; Chou C; Levine AG; Rudensky AY; Li MO
Science; 2021 Jan; 371(6527):405-410. PubMed ID: 33479154
[TBL] [Abstract][Full Text] [Related]
40. Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells.
Chen F; Chen J; Yang L; Liu J; Zhang X; Zhang Y; Tu Q; Yin D; Lin D; Wong PP; Huang D; Xing Y; Zhao J; Li M; Liu Q; Su F; Su S; Song E
Nat Cell Biol; 2019 Apr; 21(4):498-510. PubMed ID: 30936474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
